Dawn L. Hershman on Preventing CIPN in Patients With Diabetes

Video

Dawn L. Hershman, MD, MS, Columbia University Medical Center, discusses preventing chemotherapy-induced peripheral neuropathy (CIPN) in diabetic patients with cancer.

Dawn L. Hershman, MD, MS, Columbia University Medical Center, discusses preventing chemotherapy-induced peripheral neuropathy (CIPN) in diabetic patients with cancer.

Clinicians treating patients who already have diabetes-related neuropathy need to be careful in prescribing certain chemotherapy drugs that may worsen the neuropathy, especially in the palliative care setting where there may not be much benefit. For patients who may see a marginal benefit with chemotherapy, perhaps clinicians would consider prescribing docetaxel instead of paclitaxel to reduce CIPN risk.

Recent Videos
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
Man standing in front of Oncology Nursing News-branded backdrop
Image of a woman in an office, taken as a screenshot from the video interview
woman in front of a dark blue background for Oschner Health
Related Content